Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking

Biomaterials

Volumn 33, Issue 18, 2012, Pages 4515-4525

  Andreas, Kristin ^a   Georgieva, Radostina ^a   Ladwig, Mechthild ^a   Mueller, Susanne ^a   Notter, Michael ^a   Sittinger, Michael ^a   Ringe, Jochen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

In vivo cell tracking; Magnetic cell labeling; Magnetic resonance imaging; Mesenchymal stem cell; Superparamagnetic iron oxide nanoparticles; Tissue engineering

Indexed keywords

ADIPOGENIC; CELL SURFACE MARKER; CELL TRACKING; CELL-BASED THERAPY; CELLULAR FUNCTION; CHONDROGENIC DIFFERENTIATION; EX-VIVO; HUMAN MESENCHYMAL STEM CELLS; IN-VITRO; IN-VIVO; INTRAMUSCULAR INJECTIONS; LABELED CELLS; MAGNETIC CELL LABELING; MAGNETIC LABELING; MAGNETIC LABELS; MESENCHYMAL STEM CELL; OSTEOGENIC; PRUSSIAN BLUE; STEM CELL LABELING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TRANSFECTION AGENTS;

BIOCHEMISTRY; CELL MEMBRANES; CELL PROLIFERATION; EFFICIENCY; FLOWCHARTING; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MOLECULAR BIOLOGY; STEM CELLS; SUPERPARAMAGNETISM; TISSUE ENGINEERING; VISUALIZATION;

CELL CULTURE;

CELL ANTIGEN; CELL SURFACE MARKER; CITRIC ACID; FERRIC FERROCYANIDE; FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL TRACKING; CHEMOTAXIS; CHONDROGENESIS; CONTROLLED STUDY; EX VIVO STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LABELING INDEX; MAGNETISM; MALE; MATERIAL COATING; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CITRIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS;

RATTUS;

EID: 84859813404     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.064     Document Type: Article

References (53)

1. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 2004, 10(8):858-864.
2. Barry F.P., Murphy J.M Mesenchymal stem cells: clinical applications and biological characterization Int J Biochem Cell Biol 2004, 36(4):568-584.
3. Wang Y., Deng Y., Zhou G.Q SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model Brain Res 2008, 1195:104-112.
4. Chamberlain G., Fox J., Ashton B., Middleton J Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing Stem Cells 2007, 25(11):2739-2749.
5. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R., et al Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke Brain 2011, 134(Pt 6):1790-1807.
6. Assis A.C., Carvalho J.L., Jacoby B.A., Ferreira R.L., Castanheira P., Diniz S.O., et al Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart Cell Transplant 2010, 19(2):219-230.
7. Krause U., Harter C., Seckinger A., Wolf D., Reinhard A., Bea F., et al Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart Stem Cells Dev 2007, 16(1):31-37.
8. Granero-Molto F., Weis J.A., Miga M.I., Landis B., Myers T.J., O'Rear L., et al Regenerative effects of transplanted mesenchymal stem cells in fracture healing Stem Cells 2009, 27(8):1887-1898.
9. Bulte J.W., Duncan I.D., Frank J.A In vivo magnetic resonance tracking of magnetically labeled cells after transplantation J Cereb Blood Flow Metab 2002, 22(8):899-907.
10. Bulte J.W In vivo MRI cell tracking: clinical studies AJR Am J Roentgenol 2009, 193(2):314-325.
11. Wang Y.X., Hussain S.M., Krestin G.P Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging Eur Radiol 2001, 11(11):2319-2331.
12. Bernsen M.R., Moelker A.D., Wielopolski P.A., van Tiel S.T., Krestin G.P Labelling of mammalian cells for visualisation by MRI Eur Radiol 2010, 20(2):255-274.
13. Bos C., Delmas Y., Desmouliere A., Solanilla A., Hauger O., Grosset C., et al In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver Radiology 2004, 233(3):781-789.
14. Ju S., Teng G.J., Lu H., Jin J., Zhang Y., Zhang A., et al In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver Invest Radiol 2010, 45(10):625-633.
15. Kim Y.J., Huh Y.M., Choe K.O., Choi B.W., Choi E.J., Jang Y., et al In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement Int J Cardiovasc Imaging 2009, 25(Suppl 1):99-109.
16. Winkler T., von Roth P., Schuman M.R., Sieland K., Stoltenburg-Didinger G., Taupitz M., et al In vivo visualization of locally transplanted mesenchymal stem cells in the severely injured muscle in rats Tissue Eng Part A 2008, 14(7):1149-1160.
17. Jendelova P., Herynek V., Urdzikova L., Glogarova K., Kroupova J., Andersson B., et al Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord J Neurosci Res 2004, 76(2):232-243.
18. Reimer P., Balzer T Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications Eur Radiol 2003, 13(6):1266-1276.
19. Babic M., Horak D., Trchova M., Jendelova P., Glogarova K., Lesny P., et al Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling Bioconjug Chem 2008, 19(3):740-750.
20. Frank J.A., Miller B.R., Arbab A.S., Zywicke H.A., Jordan E.K., Lewis B.K., et al Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents Radiology 2003, 228(2):480-487.
21. Mahmoudi M., Hosseinkhani H., Hosseinkhani M., Boutry S., Simchi A., Journeay W.S., et al Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine Chem Rev 2011, 111(2):253-280.
22. Frank J.A., Zywicke H., Jordan E.K., Mitchell J., Lewis B.K., Miller B., et al Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents Acad Radiol 2002, 9(Suppl 2):S484-S487.
23. Wilhelm C., Billotey C., Roger J., Pons J.N., Bacri J.C., Gazeau F Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating Biomaterials 2003, 24(6):1001-1011.
24. Wilhelm C., Gazeau F Universal cell labelling with anionic magnetic nanoparticles Biomaterials 2008, 29(22):3161-3174.
25. Billotey C., Wilhelm C., Devaud M., Bacri J.C., Bittoun J., Gazeau F Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging Magn Reson Med 2003, 49(4):646-654.
26. Safi M., Sarrouj H., Sandre O., Mignet N., Berret J.F Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state Nanotechnology 2010, 21(14):145103.
27. Fleige G., Seeberger F., Laux D., Kresse M., Taupitz M., Pilgrimm H., et al In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking Invest Radiol 2002, 37(9):482-488.
28. Binger T., Stich S., Andreas K., Kaps C., Sezer O., Notter M., et al Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25 Exp Cell Res 2009, 315(8):1468-1479.
29. Ringe J., Strassburg S., Neumann K., Endres M., Notter M., Burmester G.R., et al Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2 J Cell Biochem 2007, 101(1):135-146.
30. Gimble J.M., Youkhana K., Hua X., Bass H., Medina K., Sullivan M., et al Adipogenesis in a myeloid supporting bone marrow stromal cell line J Cell Biochem 1992, 50(1):73-82.
31. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al Multilineage potential of adult human mesenchymal stem cells Science 1999, 284(5411):143-147.
32. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., et al Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI Blood 2004, 104(4):1217-1223.
33. Bulte J.W., Douglas T., Witwer B., Zhang S.C., Strable E., Lewis B.K., et al Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells Nat Biotechnol 2001, 19(12):1141-1147.
34. Arbab A.S., Yocum G.T., Wilson L.B., Parwana A., Jordan E.K., Kalish H., et al Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability Mol Imaging 2004, 3(1):24-32.
35. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat Biotechnol 2000, 18(4):410-414.
36. Josephson L., Tung C.H., Moore A., Weissleder R High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates Bioconjug Chem 1999, 10(2):186-191.
37. Zhang Y., Kohler N., Zhang M Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake Biomaterials 2002, 23(7):1553-1561.
38. Bulte J.W., Hoekstra Y., Kamman R.L., Magin R.L., Webb A.G., Briggs R.W., et al Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles Magn Reson Med 1992, 25(1):148-157.
39. Gamarra L.F., Pavon L.F., Marti L.C., Pontuschka W.M., Mamani J.B., Carneiro S.M., et al In vitro study of CD133 human stem cells labeled with superparamagnetic iron oxide nanoparticles Nanomedicine 2008, 4(4):330-339.
40. Mailander V., Lorenz M.R., Holzapfel V., Musyanovych A., Fuchs K., Wiesneth M., et al Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents Mol Imaging Biol 2008, 10(3):138-146.
41. Matuszewski L., Persigehl T., Wall A., Schwindt W., Tombach B., Fobker M., et al Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency Radiology 2005, 235(1):155-161.
42. Thorek D.L., Tsourkas A Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells Biomaterials 2008, 29(26):3583-3590.
43. Chithrani B.D., Ghazani A.A., Chan W.C Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett 2006, 6(4):662-668.
44. Schäfer R., Kehlbach R., Muller M., Bantleon R., Kluba T., Ayturan M., et al Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability Cytotherapy 2009, 11(1):68-78.
45. Bulte J.W., Kraitchman D.L., Mackay A.M., Pittenger M.F Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides Blood 2004, 104(10):3410-3412 [author reply 3412-3413].
46. Kostura L., Kraitchman D.L., Mackay A.M., Pittenger M.F., Bulte J.W Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis NMR Biomed 2004, 17(7):513-517.
47. Henning T.D., Sutton E.J., Kim A., Golovko D., Horvai A., Ackerman L., et al The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells Contrast Media Mol Imaging 2009, 4(4):165-173.
48. Lee E.S., Chan J., Shuter B., Tan L.G., Chong M.S., Ramachandra D.L., et al Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging Stem Cells 2009, 27(8):1921-1931.
49. Balakumaran A., Pawelczyk E., Ren J., Sworder B., Chaudhry A., Sabatino M., et al Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their " stemness" PLoS One 2010, 5(7):e11462.
50. Arbab A.S., Yocum G.T., Rad A.M., Khakoo A.Y., Fellowes V., Read E.J., et al Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells NMR Biomed 2005, 18(8):553-559.
51. Soenen S.J., Himmelreich U., Nuytten N., De Cuyper M Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling Biomaterials 2011, 32(1):195-205.
52. Nohroudi K., Arnhold S., Berhorn T., Addicks K., Hoehn M., Himmelreich U In vivo MRI stem cell tracking requires balancing of detection limit and cell viability Cell Transplant 2010, 19(4):431-441.
53. Cengelli F., Maysinger D., Tschudi-Monnet F., Montet X., Corot C., Petri-Fink A., et al Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures J Pharmacol Exp Ther 2006, 318(1):108-116.